1-56867638-C-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000562.3(C8A):c.107C>A(p.Ala36Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0137 in 1,613,714 control chromosomes in the GnomAD database, including 732 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A36V) has been classified as Uncertain significance.
Frequency
Consequence
NM_000562.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C8A | NM_000562.3 | c.107C>A | p.Ala36Glu | missense_variant | 2/11 | ENST00000361249.4 | |
C8A | XM_017002234.2 | c.107C>A | p.Ala36Glu | missense_variant | 2/8 | ||
C8A | XM_011542079.3 | c.107C>A | p.Ala36Glu | missense_variant | 2/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C8A | ENST00000361249.4 | c.107C>A | p.Ala36Glu | missense_variant | 2/11 | 1 | NM_000562.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00890 AC: 1354AN: 152182Hom.: 52 Cov.: 32
GnomAD3 exomes AF: 0.0196 AC: 4928AN: 251026Hom.: 238 AF XY: 0.0252 AC XY: 3414AN XY: 135648
GnomAD4 exome AF: 0.0142 AC: 20753AN: 1461414Hom.: 680 Cov.: 31 AF XY: 0.0174 AC XY: 12666AN XY: 727028
GnomAD4 genome AF: 0.00889 AC: 1354AN: 152300Hom.: 52 Cov.: 32 AF XY: 0.00999 AC XY: 744AN XY: 74460
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Type I complement component 8 deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 21, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at